Nifty
Sensex
:
:
13055.15
44523.02
128.70 (1.00%)
445.87 (1.01%)

Pharmaceuticals & Drugs - Global

Rating :
47/99  (View)

BSE: 506690 | NSE: UNICHEMLAB

258.00
8.25 (3.30%)
24-Nov-2020 | 3:53PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  252.50
  •  263.40
  •  249.75
  •  249.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  269043
  •  694.13
  •  304.70
  •  80.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,747.12
  • N/A
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,697.34
  • 1.61%
  • 0.70

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.93%
  • 3.15%
  • 30.53%
  • FII
  • DII
  • Others
  • 1.59%
  • 8.69%
  • 5.11%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.92
  • -1.90
  • -4.27

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.35
  • 23.89
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.51
  • 0.51
  • 0.51

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 20.63
  • 26.66
  • 34.41

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
318
268
18%
317
273
16%
320
375
-15%
0
0
0
Expenses
288
295
-2%
305
293
4%
307
350
-12%
0
0
0
EBITDA
30
-27
-
12
-20
-
13
25
-47%
0
0
0
EBIDTM
9%
-10%
4%
-7%
4%
7%
0%
0%
Other Income
10
28
-64%
17
26
-36%
12
21
-43%
0
0
0
Interest
1
2
-58%
1
1
-2%
2
4
-43%
0
0
0
Depreciation
21
21
1%
21
18
13%
23
19
21%
0
0
0
PBT
18
-22
-
7
-13
-
0
23
-
0
0
0
Tax
9
1
1260%
5
-8
-
18
-9
-
0
0
0
PAT
9
-22
-
2
-6
-
-18
32
-
0
0
0
PATM
3%
-8%
1%
-2%
-6%
8%
0%
0%
EPS
1.24
-3.15
-
0.34
-0.85
-
-2.53
4.52
-
0.00
0.00
0

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
-
1,211
1,188
1,380
1,540
1,333
1,202
1,133
1,081
875
824
Net Sales Growth
-
2%
-14%
-10%
16%
11%
6%
5%
23%
6%
 
Cost Of Goods Sold
-
308
364
275
189
387
379
333
343
279
238
Gross Profit
-
902
824
1,105
1,351
946
823
801
738
597
586
GP Margin
-
75%
69%
80%
88%
71%
68%
71%
68%
68%
71%
Total Expenditure
-
1,261
1,269
1,358
1,358
1,169
1,101
956
910
759
674
Power & Fuel Cost
-
73
76
49
42
38
39
36
31
26
22
% Of Sales
-
6%
6%
4%
3%
3%
3%
3%
3%
3%
3%
Employee Cost
-
273
239
201
169
256
223
187
165
140
124
% Of Sales
-
23%
20%
15%
11%
19%
19%
17%
15%
16%
15%
Manufacturing Exp.
-
151
147
125
104
151
145
137
119
102
103
% Of Sales
-
12%
12%
9%
7%
11%
12%
12%
11%
12%
12%
General & Admin Exp.
-
229
229
595
745
168
153
128
105
89
80
% Of Sales
-
19%
19%
43%
48%
13%
13%
11%
10%
10%
10%
Selling & Distn. Exp.
-
223
197
108
108
167
157
134
136
116
107
% Of Sales
-
18%
17%
8%
7%
13%
13%
12%
13%
13%
13%
Miscellaneous Exp.
-
4
16
5
2
3
4
1
11
8
107
% Of Sales
-
0%
1%
0%
0%
0%
0%
0%
1%
1%
0%
EBITDA
-
-51
-81
22
182
164
101
178
171
116
150
EBITDA Margin
-
-4%
-7%
2%
12%
12%
8%
16%
16%
13%
18%
Other Income
-
91
98
3,278
6
19
21
42
17
12
8
Interest
-
8
8
8
3
3
3
3
3
4
2
Depreciation
-
82
67
51
44
39
41
46
38
30
29
PBT
-
-49
-58
3,241
141
141
77
171
146
94
127
Tax
-
12
-34
696
33
29
2
43
33
23
32
Tax Rate
-
-24%
58%
21%
23%
21%
3%
25%
22%
24%
25%
PAT
-
-61
-24
2,545
108
108
75
128
113
71
95
PAT before Minority Interest
-
-61
-24
2,545
108
108
75
128
113
71
95
Minority Interest
-
0
0
0
0
0
0
0
0
0
0
PAT Margin
-
-5%
-2%
184%
7%
8%
6%
11%
10%
8%
12%
PAT Growth
-
-156%
-101%
2,246%
0%
44%
-41%
13%
59%
-25%
 
EPS
-
-8.66
-3.39
361.52
15.41
15.41
10.69
18.20
16.08
10.12
13.49

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
2,531
2,620
2,680
1,064
954
868
817
727
661
618
Share Capital
14
14
14
18
18
18
18
18
18
18
Total Reserves
2,512
2,602
2,665
1,044
935
849
798
708
642
599
Non-Current Liabilities
44
10
46
64
76
74
98
94
93
87
Secured Loans
0
0
0
0
23
20
25
21
20
19
Unsecured Loans
0
0
0
0
0
0
0
0
23
23
Long Term Provisions
24
15
11
25
13
9
8
9
10
8
Current Liabilities
567
503
464
393
275
212
230
251
233
176
Trade Payables
250
221
226
211
164
138
151
157
140
110
Other Current Liabilities
122
68
63
68
61
46
33
37
34
26
Short Term Borrowings
184
200
150
98
13
2
1
6
25
9
Short Term Provisions
10
13
24
16
38
26
46
52
33
31
Total Liabilities
3,142
3,133
3,190
1,521
1,305
1,153
1,145
1,072
987
881
Net Block
866
806
574
487
403
416
419
448
408
377
Gross Block
1,104
976
690
561
440
725
688
676
599
537
Accumulated Depreciation
238
170
115
74
37
309
269
228
191
160
Non Current Assets
1,455
1,094
854
772
673
589
564
594
547
456
Capital Work in Progress
330
92
238
250
237
123
91
132
113
63
Non Current Investment
134
129
9
10
6
6
6
6
0
0
Long Term Loans & Adv.
113
56
24
26
28
45
48
8
26
16
Other Non Current Assets
12
9
8
0
0
0
0
0
0
0
Current Assets
1,686
2,039
2,336
748
632
564
581
478
439
425
Current Investments
419
801
896
8
8
35
6
33
14
21
Inventories
397
339
273
282
231
208
203
143
158
150
Sundry Debtors
390
436
277
315
220
192
197
207
183
185
Cash & Bank
234
201
681
16
20
27
52
25
23
15
Other Current Assets
247
69
64
28
153
103
123
71
60
53
Short Term Loans & Adv.
183
194
146
99
123
82
106
62
53
47
Net Current Assets
1,120
1,536
1,873
356
357
353
350
227
206
249
Total Assets
3,142
3,133
3,190
1,521
1,305
1,153
1,145
1,072
987
881

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
20
-328
-112
68
112
78
87
171
124
69
PBT
-48
-57
3,241
141
138
77
171
146
94
127
Adjustment
19
7
-3,208
53
40
36
19
47
39
28
Changes in Working Capital
54
-265
-147
-99
-34
-16
-66
13
14
-55
Cash after chg. in Working capital
24
-316
-113
96
143
96
124
206
147
99
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-4
-12
1
-28
-31
-18
-37
-35
-23
-31
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-41
-286
1,648
-128
-85
-52
36
-118
-102
-48
Net Fixed Assets
-339
-139
-108
-136
155
-74
38
-93
-106
-67
Net Investments
374
-64
-889
17
42
-33
20
-34
-6
28
Others
-77
-83
2,645
-10
-282
54
-23
9
11
-9
Cash from Financing Activity
-62
-2
-881
59
-33
-51
-95
-51
-14
-29
Net Cash Inflow / Outflow
-84
-616
655
0
-7
-25
28
1
8
-8
Opening Cash & Equivalents
197
666
11
12
27
52
25
23
15
24
Closing Cash & Equivalent
226
197
666
11
20
27
52
25
23
15

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
359
372
381
117
105
95
90
80
73
68
ROA
-2%
-1%
108%
8%
9%
7%
12%
11%
8%
11%
ROE
-2%
-1%
136%
11%
12%
9%
17%
16%
11%
16%
ROCE
-1%
-2%
163%
13%
15%
9%
22%
20%
14%
20%
Fixed Asset Turnover
1.16
1.43
2.21
3.08
2.32
1.71
1.67
1.71
1.55
1.66
Receivable days
125
110
78
63
56
59
65
65
76
77
Inventory Days
111
94
73
61
59
62
55
50
64
57
Payable days
75
73
95
104
52
53
63
66
66
64
Cash Conversion Cycle
161
130
57
20
63
68
57
50
75
70
Total Debt/Equity
0.07
0.08
0.06
0.09
0.04
0.03
0.03
0.04
0.11
0.08
Interest Cover
-5
-7
406
43
49
26
55
45
24
54

News Update


  • Unichem Laboratories turns black in Q2
    2nd Nov 2020, 12:17 PM

    Total consolidated income of the company increased by 10.56% at Rs 327.55 crore for Q2FY21

    Read More
  • Unichem Lab - Quarterly Results
    31st Oct 2020, 14:25 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.